Salarius Pharmaceuticals Stock Forecast

Buy or Hold candidate since Jun 22, 2026 Loss -3.02%

The Salarius Pharmaceuticals, Inc. stock price gained 1.83% on the last trading day (Wednesday, 24th Jun 2026), rising from $6.00 to $6.11. During the last trading day the stock fluctuated 4.91% from a day low at $5.91 to a day high of $6.20. The price has risen in 8 of the last 10 days and is up by 10.89% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 909 more shares were traded than the day before. In total, 4 thousand shares were bought and sold for approximately $22.89 thousand.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.28% during the next 3 months and, with a 90% probability hold a price between $4.84 and $9.52 at the end of this 3-month period.

DCOY Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 09, 2026, and so far it has risen 10.89%. Further rise is indicated until a new top pivot has been found. Salarius Pharmaceuticals, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Salarius Pharmaceuticals, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $6.27. On a fall, the stock will find some support from the short-term average at $6.06. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Salarius Pharmaceuticals, Inc. stock

Salarius Pharmaceuticals, Inc. finds support from accumulated volume at $5.81 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.290 between high and low, or 4.91%. For the last week, the stock has had daily average volatility of 8.97%.

Our recommended stop-loss: $5.84 (-4.46%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 10 days ago.)

Trading Expectations (DCOY) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Salarius Pharmaceuticals, Inc. to open at $6.07, and during the day (based on 14 day Average True Range), to move between $5.73 and $6.49, which gives a possible trading interval of +/-$0.752 (+/-13.11%) up or down from last closing price. If Salarius Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 13.11% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.81 (4.91%) than the resistance at $6.43 (5.24%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Salarius Pharmaceuticals, Inc. stock A Buy?

Salarius Pharmaceuticals, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.961 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 25, 2026 - $6.07 ( 0.600%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk